Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study

Grace M. Choong, Savannah Liddell, Roberto A.Leon Ferre, Ciara C. O’Sullivan, Kathryn J. Ruddy, Tufia C. Haddad, Timothy J. Hobday, Prema P. Peethambaram, Minetta C. Liu, Matthew P. Goetz, Karthik V. Giridhar

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study'. Together they form a unique fingerprint.

Medicine & Life Sciences